Showing results (241-250 of 291) with videos related to
Sort By:
Pageof 30
Antimicrobial Agents and Chemotherapy|January 20, 2000
Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from Worldwide Surveillance Studies during the 1997-1998 respiratory seasonM E Jones, D F Sahm, N Martin, et al.Diagnostic Microbiology and Infectious Disease|January 1, 1988
Susceptibility of multiply resistant Haemophilus influenzae to newer antimicrobial agentsJ H Jorgensen, G V Doern, C Thornsberry, et al.Antimicrobial Agents and Chemotherapy|February 1, 1988
National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzaeG V Doern, J H Jorgensen, C Thornsberry, et al.Journal of Clinical Microbiology|November 1, 1985
Evaluation of the BIOGRAM antimicrobial susceptibility test systemR F D'Amato, L Hochstein, J R Vernaleo, et al.American Journal of Clinical Pathology|November 1, 1979
In-vitro activities of cefamandole and cephalothin against 1,881 clinical isolates. A multi-center studyA L Barry, F D Schoenknect, S Shadomy, et al.European Journal of Epidemiology|January 1, 1992
Identification of an epidemic strain of Acinetobacter baumannii using electrophoretic typing methodsG M Matar, E Gay, R C Cooksey, et al.Antimicrobial Agents and Chemotherapy|August 22, 2000
Phenotypic characterization of pncA mutants of Mycobacterium tuberculosisG P Morlock, J T Crawford, W R Butler, et al.Diagnostic Microbiology and Infectious Disease|May 1, 1987
RO 23-6240 (AM-833), a new fluoroquinolone: in vitro antimicrobial activity and tentative disk diffusion interpretive criteriaP C Fuchs, R N Jones, A L Barry, et al.Diagnostic Microbiology and Infectious Disease|May 1, 1987
Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicidA L Barry, T L Gavan, R N Jones, et al.Diagnostic Microbiology and Infectious Disease|July 1, 1986
In vitro evaluation of cefixime (FK027, FR17027, CL284635): spectrum against recent clinical isolates, comparative antimicrobial activity, beta-lactamase stability, and preliminary susceptibility testing criteriaP C Fuchs, R N Jones, A L Barry, et al.Pageof 30